Bharat Immunologicals Gross Profit

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Gross Profit Analysis

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Bharat Immunologicals 
Gross Profit 
 = 
Revenue 
-  
Cost of Revenue 
 = 
247.98 M

About Gross Profit

Gross Profit varies significantly from one sector to another and tells investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Compare to competition
According to company disclosure Bharat Immunologicals Biologicals Corp Ltd reported 247.98 M of gross profit. This is much higher than that of the Healthcare sector, and significantly higher than that of Gross Profit industry, The Gross Profit for all stocks is over 1000% lower than the firm.

Peer Comparison

Bharat Immunologicals Gross Profit Comparison
Bharat Immunologicals is currently under evaluation in gross profit category among related companies.

Did you try this?

Run Balance Of Power Now
   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Balance Of Power

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Fundamental Indicators

Current Bharat Immunologicals financial ratios